By otakuyassine3@gmail.com 
SkyOak Wealth LLC trimmed its stake in Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) by 20.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 776 shares of the biotechnology company’s stock after selling 195 shares during the period. SkyOak Wealth LLC’s holdings in Axon Enterprise were worth $461,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Public Sector Pension Investment Board grew its holdings in shares of Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock worth $1,240,000 after purchasing an additional 500 shares during the last quarter. CIBC Asset Management Inc boosted its position in shares of Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock valued at $4,227,000 after purchasing an additional 895 shares during the period. Foundations Investment Advisors LLC purchased a new position in Axon Enterprise during the 3rd quarter worth approximately $221,000. Sequoia Financial Advisors LLC increased its position in Axon Enterprise by 4.9% during the third quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock worth $690,000 after buying an additional 81 shares during the period. Finally, Axxcess Wealth Management LLC purchased a new stake in Axon Enterprise in the third quarter valued at approximately $814,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Axon Enterprise Price Performance
Shares of NASDAQ AXON opened at $652.18 on Friday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a one year low of $247.04 and a one year high of $698.67. The firm has a market capitalization of $49.73 billion, a P/E ratio of 168.52, a PEG ratio of 6.41 and a beta of 1.04. The company’s fifty day moving average is $619.63 and its two-hundred day moving average is $482.52.
Insider Activity at Axon Enterprise
In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, President Joshua Isner sold 20,000 shares of the business’s stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the completion of the sale, the president now owns 208,166 shares in the company, valued at $126,179,820.90. This represents a 8.77 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 over the last 90 days. Company insiders own 6.10% of the company’s stock.
Analyst Upgrades and Downgrades
AXON has been the topic of a number of recent research reports. Needham & Company LLC lifted their target price on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a report on Friday, November 8th. JMP Securities lifted their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Northland Securities boosted their price target on Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. Finally, Robert W. Baird increased their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. One analyst has rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and an average target price of $524.85.
View Our Latest Stock Report on AXON
Axon Enterprise Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
See Also
Receive News & Ratings for Axon Enterprise Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Axon Enterprise and related companies with MarketBeat.com’s FREE daily email newsletter.